Intrapleural use of tissue plasminogen activator and DNase in pleural infection
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...
Үндсэн зохиолчид: | Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2011
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
-н: Rahman, N, зэрэг
Хэвлэсэн: (2011) -
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
-н: Rahman, N, зэрэг
Хэвлэсэн: (2009) -
The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
-н: Kanellakis, N, зэрэг
Хэвлэсэн: (2018) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
-н: Kanellakis, N, зэрэг
Хэвлэсэн: (2019) -
Intrapleural streptokinase for pleural infection.
-н: Maskell, N, зэрэг
Хэвлэсэн: (2006)